The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent <i>Clostridioides difficile</i> Infection: A Retrospective Cohort Study

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent <i>Clostridioides difficile</i> Infection: A Retrospective Cohort Study

The most effective treatment for recurrent <i>Clostridioides difficile</i> infection (CDI) is faecal microbiota transplantation (FMT); however, the optimal route of administration is thus far unknown. This retrospective cohort study of 343 patients sought to evaluate the efficacy of trea...

Full description

Bibliographic Details
Main Authors:	Camilla Kara Svensson, Frederik Cold, Iben Ribberholt, Mike Zangenberg, Hengameh Chloé Mirsepasi-Lauridsen, Andreas Munk Petersen, Morten Helms
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Cells
Subjects:	<i>Clostridioides difficile</i> infection CDI faecal microbiota transplantation FMT rectal bacteriotherapy RBT
Online Access:	https://www.mdpi.com/2073-4409/11/20/3272

Similar Items

Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent <i>Clostridioides difficile</i> Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
by: Frederik Cold, et al.
Published: (2022-01-01)

The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for <i>Clostridioides difficile</i> Infection in Italy
by: Maria Chiara de Stefano, et al.
Published: (2022-04-01)

Bacteriotherapy for inflammatory bowel disease
by: Yusuke Yoshimatsu, et al.
Published: (2021-01-01)

Bezlotoxumab in Patients with a Primary <i>Clostridioides difficile</i> Infection: A Literature Review
by: Guido Granata, et al.
Published: (2022-10-01)

Fidaxomicin for the Treatment of <i>Clostridioides difficile</i> Infection in Adult Patients: An Update on Results from Randomized Controlled Trials
by: Daniele Roberto Giacobbe, et al.
Published: (2022-10-01)

The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
by: Ronald G. Hall, et al.
Published: (2022-02-01)

The Role of Bezlotoxumab for the Prevention of Recurrent <i>Clostridioides difficile</i> Infections: A Review of the Current Literature and Paradigm Shift after 2021
by: Melanie L. Hyte, et al.
Published: (2022-09-01)

Faecal transplantation and Clostridioides difficile infection
by: Knežević Darija A., et al.
Published: (2021-01-01)

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)
by: Sahil Khanna, et al.
Published: (2022-09-01)

Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing <i>Clostridioides difficile</i> Infection
by: Khalid Alyahya, et al.
Published: (2023-06-01)

Influence of Probiotics on the Development of <i>Clostridioides difficile</i> Infection in Patients Receiving Fluoroquinolones
by: Mary E. Sheffield, et al.
Published: (2021-08-01)

<i>Clostridioides difficile</i> in Pigs and Dairy Cattle in Northern Italy: Prevalence, Characterization and Comparison between Animal and Human Strains
by: Patrizia Spigaglia, et al.
Published: (2023-07-01)

Advances in Therapeutic Strategies for the Management of <i>Clostridioides difficile</i> Infection
by: Antonio Vitiello, et al.
Published: (2024-02-01)

Clostridioides difficile infection: microbe-microbe interactions and live biotherapeutics
by: Ruojun Wang
Published: (2023-05-01)

Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Clostridioides difficile Infection – A novel method for capsule faecal microbiota transfer
by: Adorján Varga, et al.
Published: (2023-01-01)

Editorial: Clostridioides difficile infection
by: Guido Granata, et al.
Published: (2024-02-01)

A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and <i>Clostridioides difficile</i> Infection
by: Bogdan Ioan Vintila, et al.
Published: (2024-02-01)

Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
by: Giovanna Batoni, et al.
Published: (2022-02-01)

Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico
by: Laura Tijerina-Rodríguez, et al.
Published: (2022-02-01)

Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020
by: Chinenye M. Okafor, et al.
Published: (2023-05-01)

Updated Management Guidelines for <i>Clostridioides difficile</i> in Paediatrics
by: Margherita Gnocchi, et al.
Published: (2020-04-01)

<i>In Vitro</i> Bactericidal Effects of Photodynamic Therapy Combined with Four Tetracyclines against <i>Clostridioides difficile</i> KCTC5009 in Planktonic Cultures
by: Sung Sook Choi, et al.
Published: (2020-04-01)

Fecal microbiota transplantation in puppies with canine parvovirus infection
by: Giorgio Q. Pereira, et al.
Published: (2018-03-01)

Comorbid status and the faecal microbial transplantation failure in treatment of recurrent Clostridioides difficile infection – pilot prospective observational cohort study
by: M. Kachlíková, et al.
Published: (2020-01-01)

Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic
by: Negin Kazemian, et al.
Published: (2021-03-01)

Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
by: Ting Gu, et al.
Published: (2022-08-01)

Design and Development of Molecular Beacon-Based Real-Time PCR Assays to Identify <i>Clostridioides difficile</i> Types of Main Evolutionary Clades
by: Enrico Maria Criscuolo, et al.
Published: (2024-03-01)

Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation
by: Dengyu Wu, et al.
Published: (2023-10-01)

Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore
by: Tay, Hui Lin, et al.
Published: (2020)

Whole Genome Sequencing Evidences High Rates of Relapse in <i>Clostridioides difficile</i> Infection Caused by the Epidemic Ribotype 106
by: Loreto Suárez-Bode, et al.
Published: (2023-01-01)

Pragmatic Strategy for Fecal Specimen Storage and the Corresponding Test Methods for <i>Clostridioides difficile</i> Diagnosis
by: Seong Won Nho, et al.
Published: (2021-08-01)

Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation
by: Omar Ahmad, et al.
Published: (2021-06-01)

Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent <i>Clostridioides difficile</i> Infection
by: Lara Šamadan, et al.
Published: (2021-06-01)

Faecal microbial transplant
by: Isreal Ayobami Onifade, et al.
Published: (2024-01-01)

Characterization of a Clostridioides difficile outbreak caused by PCR ribotype 046, associated with increased mortality
by: Cecilia Magnusson, et al.
Published: (2022-12-01)

Metabolic Phenotyping Study of Mouse Brain Following Microbiome Disruption by <i>C. difficile</i> Colonization
by: Olga Deda, et al.
Published: (2022-10-01)

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
by: Giancarlo Ceccarelli, et al.
Published: (2021-01-01)

National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
by: Kristina Rizzardi, et al.
Published: (2018-09-01)

Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic <i>Clostridioides difficile</i>
by: Cecilia Suarez-Carantoña, et al.
Published: (2021-04-01)

ESTRATÉGIAS PARA REDUÇÃO DOS CASOS DE CLOSTRIDIOIDES DIFFICILE NA UNIDADE DE TERAPIA INTENSIVA: ABORDAGEM MULTIFATORIAL
by: Luciana Rodrigues da Silva, et al.
Published: (2023-10-01)